281
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Mucoadhesive tablets for the vaginal delivery of progesterone: in vitro evaluation and pharmacokinetics/pharmacodynamics in female rabbits

, ORCID Icon, , &
Pages 224-232 | Received 02 Jun 2017, Accepted 06 Sep 2017, Published online: 23 Oct 2017

References

  • Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev. 1997;18:502–519.
  • Kaore SN, Langade DK, Yadav VK, et al. Novel actions of progesterone: what we know today and what will be the scenario in the future? J Pharm Pharmacol. 2012;64:1040–1062.
  • Ciampaglia W, Cognigni GE. Clinical use of progesterone in infertility and assisted reproduction. Acta Obstet Gynecol Scand. 2015;94(161):17–27.
  • Goletiani NV, Keith DR, Gorsky SJ. Progesterone: review of safety for clinical studies. Exp Clin Psychopharmacol. 2007;15:427–444.
  • Scavone C, Bonagura AC, Fiorentino S, et al. Efficacy and safety profile of diclofenac/cyclodextrin and progesterone/cyclodextrin formulations: a review of the literature data. Drugs R D. 2016;16:129–140.
  • Tavaniotou A, Smitz J, Bourgain C, et al. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update. 2000;6:139–148.
  • How HY, Leaseburge L, Khoury JC, et al. A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. Am J Obstet Gynecol. 2001;185:911–915.
  • De Ziegler D, Bulletti C, De Monstier B, et al. The first uterine pass effect. Ann N Y Acad Sci. 1997;828:291–299.
  • Caramella CM, Rossi S, Ferrari F, et al. Mucoadhesive and thermogelling systems for vaginal drug delivery. Adv Drug Deliv Rev. 2015;92:39–52.
  • Woolfson AD, Malcolm RK, Gallagher R. Drug delivery by the intravaginal route. Crit Rev Ther Drug Carrier Syst. 2000;17:509–555.
  • Acarturk F. Mucoadhesive vaginal drug delivery systems. Recent Pat Drug Deliv Formul. 2009;3:193–205.
  • de Araújo Pereira RR, Bruschi ML. Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 2012;38:643–652.
  • Soliman GM, Fetih G, Abbas AM. Thermosensitive bioadhesive gels for the vaginal delivery of sildenafil citrate: in vitro characterization and clinical evaluation in women using clomiphene citrate for induction of ovulation. Drug Dev Ind Pharm. 2017;43:399–408.
  • Gibbons WE, Toner JP, Hamacher P, et al. Experience with a novel vaginal progesterone preparation in a donor oocyte program. Fertil Steril. 1998;69:96–101.
  • Campaña-Seoane M, Peleteiro A, Laguna R, et al. Bioadhesive emulsions for control release of progesterone resistant to vaginal fluids clearance. Int J Pharm. 2014;477:495–505.
  • Almomen A, Cho S, Yang C-H, et al. Thermosensitive progesterone hydrogel: a safe and effective new formulation for vaginal application. Pharm Res. 2015;32:2266–2279.
  • Hassan AS, Soliman GM, El-Mahdy MM, et al. Solubilization and enhancement of ex vivo vaginal delivery of progesterone using solid dispersions, inclusion complexes and micellar solubilization. Curr Drug Deliv. 2017;14. DOI:10.2174/1567201814666170320142136
  • Perioli L, Ambrogi V, Pagano C, et al. FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration. Int J Pharm. 2009;377:120–127.
  • El-Kamel A, Sokar M, Naggar V, et al. Chitosan and sodium alginate—based bioadhesive vaginal tablets. AAPS PharmSci. 2002;4:224–230.
  • Ali J, Khar R, Ahuja A, et al. Buccoadhesive erodible disk for treatment of oro-dental infections: design and characterisation. Int J Pharm. 2002;238:93–103.
  • Wittaya-areekul S, Kruenate J, Prahsarn C. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int J Pharm. 2006;312:113–118.
  • Nafee NA, Ismail FA, Boraie NA, et al. Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm. 2004;30:985–993.
  • Iwata M, Takahashi Y, Shirotake S, et al. Effect of sodium caprate on the absorption of progesterone from mixed suppositories administered to the vagina of rabbits. Drug Dev Ind Pharm. 1997;23:167–172.
  • Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659–661.
  • Andréen L, Spigset O, Andersson A, et al. Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone. Maturitas. 2006;54:238–244.
  • Levy T, Gurevitch S, Bar-Hava I, et al. Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet. Hum Reprod. 1999;14:606–610.
  • Basu A, Shrivastav TG, Maitra SK. A direct antigen heterologous enzyme immunoassay for measuring progesterone in serum without using displacer. Steroids. 2006;71:222–230.
  • Zhang Y, Huo M, Zhou J, et al. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed. 2010;99:306–314.
  • Panchagnula R, Thomas NS. Biopharmaceutics and pharmacokinetics in drug research. Int J Pharm. 2000;201:131–150.
  • Lillie R. Histopathologic technic and practical histochemistry. New York, Toronto: The Blakiston Company Inc.; 1954.
  • Jug M, Bećirević-Laćan M. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci. 2004;21:251–260.
  • Owen DH, Katz DF. A vaginal fluid simulant. Contraception. 1999;59:91–95.
  • Cevher E, Açma A, Sinani G, et al. Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis. Int J Biol Macromol. 2014;69:124–136.
  • Yehia SA, El-Gazayerly ON, Basalious EB. Design and in vitro/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: relationship between swelling, erosion, and drug release. AAPS PharmSciTech. 2008;9:1207–1217.
  • Duttagupta DS, Jadhav VM, Kadam VJ. Chitosan: a propitious biopolymer for drug delivery. Curr Drug Deliv. 2015;12:369–381.
  • Sriamornsak P, Thirawong N, Korkerd K. Swelling, erosion and release behavior of alginate-based matrix tablets. Eur J Pharm Biopharm. 2007;66:435–450.
  • Li C, Bhatt P, Johnston T. Evaluation of a mucoadhesive buccal patch for delivery of peptides: in vitro screening of bioadhesion. Drug Dev Ind Pharm. 1998;24:919–926.
  • Gupta A, Garg S, Khar R. Interpolymer complexation and its effect on bioadhesive strength 6 dissolution characteristics of buccal drug delivery systems. Drug Dev Ind Pharm. 1994;20:315–325.
  • Deacon M, McGurk S, Roberts C, et al. Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems. Biochem J. 2000;348:557–563.
  • Nafee NA, Ismail FA, Boraie NA, et al. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int J Pharm. 2003;264:1–14.
  • Wong C, Yuen K, Peh K. Formulation and evaluation of controlled release Eudragit buccal patches. Int J Pharm. 1999;178:11–22.
  • Yehia SA, El-Gazayerly ON, Basalious EB. Fluconazole mucoadhesive buccal films: in vitro/in vivo performance. Curr Drug Deliv. 2009;6:17–27.
  • El-Gindy G, El-Sayed A, Mohamed A, et al. Mucoadhesive vaginal tablets of natamycin for vaginal candidiasis. Bull Pharm Sci Assiut Univ. 2003;26:29–40.
  • Cerchiara T, Luppi B, Bigucci F, et al. Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes. Int J Pharm. 2003;258:209–215.
  • Patel VM, Prajapati BG, Patel HV, et al. Mucoadhesive bilayer tablets of propranolol hydrochloride. AAPS PharmSciTech. 2007;8:E203–E2E8.
  • Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2012;37:106–126.
  • Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5:37–42.
  • Arora G, Malik K, Singh I, et al. Formulation and evaluation of controlled release matrix mucoadhesive tablets of domperidone using Salvia plebeian gum. J Adv Pharm Tech Res. 2011;2:163–169.
  • Szymanska E, Winnicka K, Amelian A, et al. Vaginal chitosan tablets with clotrimazole-design and evaluation of mucoadhesive properties using porcine vaginal mucosa, mucin and gelatine. Chem Pharm Bull. 2014;62:160–167.
  • Levine H, Watson N. Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus prometrium administered orally in postmenopausal women(3). Fertil Steril. 2000;73:516–521.
  • Tugcu-Demiroz F, Acarturk F, Erdogan D. Development of long-acting bioadhesive vaginal gels of oxybutynin: formulation, in vitro and in vivo evaluations. Int J Pharm. 2013;457:25–39.
  • Jameela SR, Kumary TV, Lal AV, et al. Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. J Control Release. 1998;52:17–24.
  • Matsuoka T, Mizuguchi H, Mizoguchi Y, et al. Effects of restricted feeding on blood parameters in pregnant rabbits. J Toxicol Sci. 2009;34:129–137.
  • Durnwald CP, Mercer BM. Myometrial thickness according to uterine site, gestational age and prior cesarean delivery. J Matern Fetal Neonatal Med. 2008;21:247–250.
  • Buhimschi CS, Buhimschi IA, Malinow AM, et al. Myometrial thickness during human labor and immediately post partum. Am J Obstet Gynecol. 2003;188:553–559.
  • Daya S. Luteal support: progestogens for pregnancy protection. Maturitas. 2009;65(1):S29–S34.
  • Bhowmik T, Mukherjea M. Histological changes in the ovary and uterus of rat after injectable contraceptive therapy. Contraception. 1988;37:529–538.
  • Cicinelli E, de Ziegler D, Bulletti C, et al. Direct transport of progesterone from vagina to uterus. Obstet Gynecol. 2000;95:403–406.
  • Ficicioglu C, Gurbuz B, Tasdemir S, et al. High local endometrial effect of vaginal progesterone gel. Gynecol Endocrinol. 2004;18:240–243.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.